Go back to the Europarl portal

Choisissez la langue de votre document :

  • bg - български
  • es - español
  • cs - čeština
  • da - dansk
  • de - Deutsch
  • et - eesti keel
  • el - ελληνικά
  • en - English (Selected)
  • fr - français
  • ga - Gaeilge
  • hr - hrvatski
  • it - italiano
  • lv - latviešu valoda
  • lt - lietuvių kalba
  • hu - magyar
  • mt - Malti
  • nl - Nederlands
  • pl - polski
  • pt - português
  • ro - română
  • sk - slovenčina
  • sl - slovenščina
  • fi - suomi
  • sv - svenska
Parliamentary questions
PDF 101kWORD 17k
20 March 2018
E-000528/2018(ASW)
Answer given by Mr Vella on behalf of the Commission
Question reference: E-000528/2018

At the plenary meeting of the European Parliament on 5 February 2018, the Commission condemned in the strongest possible manner the private tests performed on humans and monkeys that have been financed by Volkswagen, Daimler and BMW. These tests are not required by the EU vehicle type-approval legislation, nor by any other EU legislation.

The EU has among the highest standards on clinical trials and animal testing. Considering the strict rules that govern the use of animal testing in the EU, it is the firm belief of the Commission that such testing on animals would not be considered justified in the territory of the EU.

It is the responsibility of the Member States to ensure that these rules and standards are respected. While the tests on monkeys were performed outside the EU territory and therefore do not fall under the provisions of the EU Directive governing animal tests(1), the trials on humans were performed in Germany, which has already indicated it would investigate the matter.

(1)Directive 2010/63/EU, OJ L 276, 20.10.2010, p. 33‐79.

Last updated: 22 March 2018Legal notice - Privacy policy